{"id":43310,"date":"2025-12-23T05:43:15","date_gmt":"2025-12-23T05:43:15","guid":{"rendered":"https:\/\/news.godj.com\/news\/wegovy-pill-approved-by-us-fda-for-weight-loss\/"},"modified":"2025-12-23T05:43:15","modified_gmt":"2025-12-23T05:43:15","slug":"wegovy-pill-approved-by-us-fda-for-weight-loss","status":"publish","type":"post","link":"https:\/\/news.godj.com\/news\/wegovy-pill-approved-by-us-fda-for-weight-loss\/","title":{"rendered":"Wegovy pill approved by US FDA for weight loss"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div data-component=\"text-block\">\n<p class=\"sc-9a00e533-0 eZyhnA\">The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to<b id=\"\" class=\"sc-d16436d-0 gnUCoQ\"> <\/b>pharmaceutical giant Novo Nordisk.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">It is the first pill of its kind to receive approval from the regulator, marking a new era for weight-loss drugs.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">Wegovy&#8217;s Danish makers Novo Nordisk said the once-daily pill was a &#8220;convenient option&#8221; to the injectable<b id=\"\" class=\"sc-d16436d-0 gnUCoQ\"> <\/b>and would provide the same weight loss as the shot. It comes after Wegovy was approved by the FDA specifically for weight loss.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">Others like Ozempic, which has similar weight-loss effects, were primarily approved for the treatment of Type 2 diabetes.<\/p>\n<\/div>\n<div data-component=\"text-block\">\n<p class=\"sc-9a00e533-0 eZyhnA\">The BBC has contacted the FDA for comment.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">The Wegovy pill showed an average weight loss of 16.6% during Novo Nordisk&#8217;s trials, <a target=\"_blank\" href=\"https:\/\/www.novonordisk.com\/content\/nncorp\/global\/en\/news-and-media\/news-and-ir-materials\/news-details.html?id=916472\" class=\"sc-f9178328-0 iCaRzc\">the firm said<\/a> on Monday.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">A third of around 1,300 participants experienced 20% or greater weight loss in the same trial, it added.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">The pill is expected to be launched in the US in early January 2026.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">&#8220;Patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy injection,&#8221; said Mike Doustdar, the firm&#8217;s chief executive.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">The pill version of Wegovy could give Novo Nordisk&#8217;s sales a boost after a challenging year which saw its shares slide as it warned over its profits.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">The company has faced intense competition in the weight-loss market from rival drugmakers like Eli Lilly.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">Novo Nordisk&#8217;s shares rose by almost 10% in after-hours trade in New York after the announcement.<\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.bbc.com\/news\/articles\/ce86le5dyxyo?at_medium=RSS&#038;at_campaign=rss\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. It is the first pill of its kind to receive approval from the regulator, marking a new era for weight-loss drugs. Wegovy&#8217;s Danish makers Novo Nordisk said the once-daily pill was a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":43311,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[53],"tags":[5017,13064,1608,6733,6895,4209],"class_list":["post-43310","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-approved","tag-fda","tag-loss","tag-pill","tag-wegovy","tag-weight"],"_links":{"self":[{"href":"https:\/\/news.godj.com\/news\/wp-json\/wp\/v2\/posts\/43310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/news.godj.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.godj.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.godj.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news.godj.com\/news\/wp-json\/wp\/v2\/comments?post=43310"}],"version-history":[{"count":1,"href":"https:\/\/news.godj.com\/news\/wp-json\/wp\/v2\/posts\/43310\/revisions"}],"predecessor-version":[{"id":43312,"href":"https:\/\/news.godj.com\/news\/wp-json\/wp\/v2\/posts\/43310\/revisions\/43312"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news.godj.com\/news\/wp-json\/wp\/v2\/media\/43311"}],"wp:attachment":[{"href":"https:\/\/news.godj.com\/news\/wp-json\/wp\/v2\/media?parent=43310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.godj.com\/news\/wp-json\/wp\/v2\/categories?post=43310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.godj.com\/news\/wp-json\/wp\/v2\/tags?post=43310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}